Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Pasquale Molinari"'
Autor:
Girolamo Ranieri, Sara Sablone, Vito Fazio, Dario De Ceglia, Mariangela Porcelli, Pasquale Molinari, Livia Fucci, Carmelo Laface, Cosmo Damiano Gadaleta
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Patients affected by pancreatic ductal adenocarcinoma (PDAC) have very poor prognosis, whereby at a follow-up of 5 years, the mortality rate is very similar to the incidence rate. Globally, around 10% of patients are amenable to radical surgery at th
Externí odkaz:
https://doaj.org/article/e7d786bfa72b4b708cf4b72a48e1d03f
Autor:
Girolamo Ranieri, Carmelo Laface, Mariarita Laforgia, Simona De Summa, Mariangela Porcelli, Francesco Macina, Michele Ammendola, Pasquale Molinari, Gianfranco Lauletta, Alessandra Di Palo, Giuseppe Rubini, Cristina Ferrari, Cosmo Damiano Gadaleta
Publikováno v:
Frontiers in Oncology, Vol 10 (2021)
Externí odkaz:
https://doaj.org/article/ea7a808c11b44361947ccbced352073c
Autor:
Girolamo Ranieri, Carmelo Laface, Mariarita Laforgia, Simona De Summa, Mariangela Porcelli, Francesco Macina, Michele Ammendola, Pasquale Molinari, Gianfranco Lauletta, Alessandra Di Palo, Giuseppe Rubini, Cristina Ferrari, Cosmo Damiano Gadaleta
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Bevacizumab plus FOLFOX-4 regimen represents the first-line therapy in patients affected by metastatic colorectal cancer (mCRC). Hyperthermia has been considered an effective ancillary treatment for cancer therapy through several anti-tumor mechanism
Externí odkaz:
https://doaj.org/article/2a2e94266a8a4d06a9743aeb670e60a5
Autor:
Carmelo Laface, Cosmo Damiano Gadaleta, Mariarita Laforgia, Ippazio Ugenti, Girolamo Ranieri, Pasquale Molinari, Camillo Porta
Publikováno v:
Cancers
Cancers, Vol 13, Iss 3091, p 3091 (2021)
Cancers, Vol 13, Iss 3091, p 3091 (2021)
Simple Summary Liver functional failure is one of the leading causes of cancer-related death. Systemic chemotherapy usually offers a modest benefit in terms of disease control rate, progression-free survival, and overall survival at the cost of a sig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9f568be032b8835070694256e9e391a
http://europepmc.org/articles/PMC8234226
http://europepmc.org/articles/PMC8234226
Autor:
Carmelo Laface, Palma Fedele, Felicia Maria Maselli, Francesca Ambrogio, Caterina Foti, Pasquale Molinari, Michele Ammendola, Marco Lioce, Girolamo Ranieri
Publikováno v:
Cancers. 14:4028
Hepatocellular carcinoma (HCC) is the most frequent primitive cancer of the liver, accounting for 90% of all recorded cases. HCC is the third most common cause of cancer-related death, with a 5-year survival rate of just 3%. In the advanced stages, s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e381766320b2759a6192af4941292c27
https://doi.org/10.3390/cancers14164028
https://doi.org/10.3390/cancers14164028
Autor:
Michele Ammendola, Mariarita Laforgia, Cristina Ferrari, Francesco Macina, Mariangela Porcelli, Pasquale Molinari, Simona De Summa, Cosmo Damiano Gadaleta, Carmelo Laface, Girolamo Ranieri, Gianfranco Lauletta, Giuseppe Rubini, Alessandra Di Palo
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncology
Frontiers in Oncology, Vol 10 (2021)
Frontiers in Oncology
Frontiers in Oncology, Vol 10 (2021)
Bevacizumab plus FOLFOX-4 regimen represents the first-line therapy in patients affected by metastatic colorectal cancer (mCRC). Hyperthermia has been considered an effective ancillary treatment for cancer therapy through several anti-tumor mechanism
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8131db34b898d842d861f727346fe052
https://doi.org/10.3389/fonc.2020.637880
https://doi.org/10.3389/fonc.2020.637880
Autor:
Carmelo Laface, Mariarita Laforgia, Pasquale Molinari, Caterina Foti, Francesca Ambrogio, Cosmo Damiano Gadaleta, Girolamo Ranieri
Publikováno v:
Cancers, Vol 14, Iss 450, p 450 (2022)
Cancers
Cancers
Simple Summary Pancreatic cancer has a very poor prognosis. The few available therapeutic options are characterized by low efficacy and high toxicity due to the intrinsic chemoresistance of this tumor type. To improve clinical results, some clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a285eaab64e269ac4776a5f9cd9c84e
https://doi.org/10.3390/cancers14020450
https://doi.org/10.3390/cancers14020450
Autor:
Pasquale Molinari, Marco Lopetuso, Vito Michele Fazio, Carmelo Laface, Cosmo Damiano Gadaleta, Gianmarco Falagario, Girolamo Ranieri, Giovanni Mastrandrea
Publikováno v:
Medicine. 100:e27730
RATIONALE According to scientific literature, cryoablation (CA) and electrochemotherapy (ECT) have been used for the treatment of small renal masses. However, no data have been published regarding the combination of these techniques as therapy of pri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::470484e6ffc90628eac06f37dfd0a329
https://doi.org/10.1097/md.0000000000027730
https://doi.org/10.1097/md.0000000000027730
Autor:
Patrizia Nardulli, Simona Ferraiuolo, Ilaria Marech, Cosmo Damiano Gadaleta, Pasquale Molinari, Girolamo Ranieri, Mariarita Laforgia
Publikováno v:
Cancers
Cancers, Vol 11, Iss 2, p 141 (2019)
Cancers, Vol 11, Iss 2, p 141 (2019)
Liver metastases (LM) are often consequences of colo-rectal cancer (CRC)and the majority of patients have unresectable LM. Oxaliplatin-based intravenous chemotherapy represents the gold standard treatment for CRC. Intravenous oxaliplatin has several
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8c5260290fc8cb85cc1a3c83afeb57a
https://doi.org/10.3390/cancers11020141
https://doi.org/10.3390/cancers11020141